Company page

Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. is a public company traded under the ticker COAG in the American market. The company has a market capitalization of approximately $1.17 billion. Hemab focuses on developing innovative therapies to address unmet medical needs.

profileCOAG:NASDAQAI content: aiUpdated June 24, 2026/company/hemab-therapeutics-holdings-inc/c-pf9sdjh3
Hemab Therapeutics Holdings, Inc. logo
Ticker
COAG:NASDAQ
Asset type
Stock
Market cap
$1.17B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD